Add Your Heading Text Here

Neurodegenerative Diseases Research Topics

These neurodegenerative diseases thesis topics are designed for MD Medicine and DNB Medicine candidates studying Parkinson disease, dementias, motor neuron disease, atypical parkinsonism, hereditary choreiform disorders, degenerative ataxias and related syndromes. The emphasis is on clinically feasible work that can be completed within one thesis period using patients, neurological examination, cognitive and functional scales, routine laboratory tests, neuroimaging and other investigations already available during standard care. Strong projects define the neurodegenerative phenotype carefully, use validated instruments and separate disease severity from age, education, frailty and comorbidity. The same framework can be adapted for neurodegenerative disease research topics, an MD Medicine neurodegenerative diseases protocol or a DNB Medicine neurodegenerative diseases synopsis before final discussion with the postgraduate guide.

Last reviewed and updated: September 2026 · 2026–27 admissions

Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.

Parkinson Disease

  1. Clinical profile and spectrum of motor and non-motor manifestations among adults with Parkinson disease attending a tertiary care hospital: a cross-sectional observational study
  2. Association of age and duration of illness with motor severity among adults with Parkinson disease: a cross-sectional analytical study
  3. Relationship between tremor severity and functional disability among patients with Parkinson disease: a cross-sectional observational study
  4. Comparison of clinical characteristics of tremor-dominant and akinetic-rigid phenotypes of Parkinson disease: a comparative cross-sectional study
  5. Association of body mass index with motor severity among adults with Parkinson disease: a cross-sectional analytical study
  6. Prevalence of undernutrition among adults with Parkinson disease and its association with functional disability: a cross-sectional study
  7. Association of mid-upper arm circumference with functional status among patients with Parkinson disease: a cross-sectional analytical study
  8. Comparison of nutritional status between patients with mild and advanced Parkinson disease: a comparative cross-sectional study
  9. Prevalence of anaemia among adults with Parkinson disease and its association with functional impairment: a cross-sectional observational study
  10. Association of haemoglobin concentration with mobility limitation among patients with Parkinson disease: a cross-sectional analytical study
  11. Prevalence of vitamin B12 deficiency among adults with Parkinson disease and its association with neurological disability: a cross-sectional study
  12. Comparison of vitamin B12 status between patients with Parkinson disease with and without cognitive impairment: a comparative cross-sectional study
  13. Association of serum vitamin D concentration with postural instability among patients with Parkinson disease: a cross-sectional analytical study
  14. Prevalence of vitamin D deficiency among adults with Parkinson disease and its association with fall risk: a cross-sectional study
  15. Association of serum uric acid with motor severity among adults with Parkinson disease: a cross-sectional observational study
  16. Relationship between serum albumin and functional status among patients with Parkinson disease: a cross-sectional analytical study
  17. Prevalence of orthostatic hypotension among adults with Parkinson disease: a cross-sectional observational study
  18. Association of orthostatic hypotension with disease severity among patients with Parkinson disease: a cross-sectional analytical study
  19. Comparison of clinical characteristics of Parkinson disease patients with and without orthostatic hypotension: a comparative cross-sectional study
  20. Prevalence of constipation among adults with Parkinson disease and its association with disease severity: a cross-sectional study
  21. Association of constipation severity with autonomic dysfunction among patients with Parkinson disease: a cross-sectional analytical study
  22. Prevalence of urinary symptoms among patients with Parkinson disease and their association with functional disability: a cross-sectional observational study
  23. Comparison of autonomic symptom burden between men and women with Parkinson disease: a comparative cross-sectional study
  24. Prevalence of excessive daytime sleepiness among adults with Parkinson disease: a cross-sectional study
  25. Association of excessive daytime sleepiness with motor severity among patients with Parkinson disease: a cross-sectional analytical study
  26. Relationship between sleep quality and functional disability among adults with Parkinson disease: a cross-sectional observational study
  27. Comparison of sleep quality between patients with early-stage and advanced Parkinson disease: a comparative cross-sectional study
  28. Prevalence of rapid eye movement sleep behaviour disorder symptoms among adults with Parkinson disease: a cross-sectional study
  29. Association of probable rapid eye movement sleep behaviour disorder with cognitive impairment in Parkinson disease: a cross-sectional analytical study
  30. Prevalence of depressive symptoms among adults with Parkinson disease and their association with motor disability: a cross-sectional study
  31. Association of depressive symptom severity with quality of life among patients with Parkinson disease: a cross-sectional analytical study
  32. Comparison of motor and non-motor symptom burden among Parkinson disease patients with and without depressive symptoms: a comparative cross-sectional study
  33. Prevalence of anxiety symptoms among adults with Parkinson disease: a cross-sectional observational study
  34. Association of anxiety symptoms with tremor severity among patients with Parkinson disease: a cross-sectional analytical study
  35. Prevalence of cognitive impairment among adults with Parkinson disease attending a tertiary care hospital: a cross-sectional study
  36. Association of age, education, and disease severity with cognitive impairment among patients with Parkinson disease: a cross-sectional analytical study
  37. Comparison of clinical characteristics of Parkinson disease patients with and without cognitive impairment: a comparative cross-sectional study
  38. Relationship between executive dysfunction and motor severity among patients with Parkinson disease: a cross-sectional observational study
  39. Association of gait impairment with cognitive dysfunction among adults with Parkinson disease: a cross-sectional analytical study
  40. Prevalence of falls among adults with Parkinson disease and their associated clinical factors: a cross-sectional study
  41. Association of postural instability with fall risk among adults with Parkinson disease: a cross-sectional analytical study
  42. Comparison of clinical characteristics of Parkinson disease patients with and without recurrent falls: a comparative cross-sectional study
  43. Association of freezing of gait with disease severity among adults with Parkinson disease: a cross-sectional observational study
  44. Relationship between lower limb muscle strength and mobility limitation in Parkinson disease: a cross-sectional analytical study
  45. Comparison of functional mobility between tremor-dominant and postural-instability-dominant Parkinson disease: a comparative cross-sectional study
  46. Prevalence of dysphagia symptoms among adults with Parkinson disease: a cross-sectional observational study
  47. Association of dysphagia with nutritional status among adults with Parkinson disease: a cross-sectional analytical study
  48. Comparison of nutritional parameters between Parkinson disease patients with and without swallowing difficulty: a comparative cross-sectional study
  49. Prevalence of drooling among patients with Parkinson disease and its association with disease severity: a cross-sectional study
  50. Association of speech impairment with functional disability among adults with Parkinson disease: a cross-sectional analytical study
  51. Prevalence of olfactory dysfunction among adults with Parkinson disease and its association with non-motor symptom burden: a cross-sectional observational study
  52. Association of impaired smell perception with cognitive impairment among patients with Parkinson disease: a cross-sectional analytical study
  53. Prevalence of metabolic syndrome among adults with Parkinson disease: a cross-sectional study
  54. Comparison of metabolic risk factors between Parkinson disease patients and age-matched adults without neurodegenerative disease: a comparative cross-sectional study
  55. Association of diabetes mellitus with motor severity among adults with Parkinson disease: a cross-sectional analytical study
  56. Comparison of clinical characteristics of Parkinson disease patients with and without diabetes mellitus: a comparative cross-sectional study
  57. Association of hypertension with cognitive impairment among older adults with Parkinson disease: a cross-sectional analytical study
  58. Prevalence of electrocardiographic abnormalities among adults with Parkinson disease and autonomic symptoms: a cross-sectional observational study
  59. Association of polypharmacy with orthostatic symptoms and falls among older adults with Parkinson disease: a cross-sectional analytical study
  60. Comparison of motor severity, cognitive impairment, autonomic symptoms, and nutritional status across different clinical stages of Parkinson disease: a comparative cross-sectional study

Alzheimer Disease and Other Common Dementias

  1. Clinical and cognitive profile of older adults with Alzheimer disease attending a tertiary care hospital: a cross-sectional observational study
  2. Association of age and educational status with cognitive severity among patients with Alzheimer disease: a cross-sectional analytical study
  3. Relationship between duration of cognitive symptoms and severity of functional dependence among adults with Alzheimer disease: a cross-sectional observational study
  4. Comparison of cognitive and functional characteristics of early-onset and late-onset Alzheimer disease: a comparative cross-sectional study
  5. Prevalence of behavioural and psychological symptoms among adults with Alzheimer disease: a cross-sectional study
  6. Association of behavioural symptom burden with severity of cognitive impairment among patients with Alzheimer disease: a cross-sectional analytical study
  7. Comparison of cognitive characteristics of patients with Alzheimer disease with and without prominent behavioural symptoms: a comparative cross-sectional study
  8. Prevalence of depressive symptoms among adults with Alzheimer disease and their association with cognitive severity: a cross-sectional study
  9. Association of anxiety symptoms with functional dependence among patients with Alzheimer disease: a cross-sectional analytical study
  10. Prevalence of sleep disturbance among adults with Alzheimer disease: a cross-sectional observational study
  11. Association of poor sleep quality with cognitive impairment among patients with Alzheimer disease: a cross-sectional analytical study
  12. Comparison of cognitive performance among Alzheimer disease patients with and without significant sleep disturbance: a comparative cross-sectional study
  13. Prevalence of nutritional impairment among older adults with Alzheimer disease: a cross-sectional study
  14. Association of body mass index with cognitive and functional severity among patients with Alzheimer disease: a cross-sectional analytical study
  15. Relationship between serum albumin and functional dependence among older adults with Alzheimer disease: a cross-sectional observational study
  16. Comparison of nutritional status between patients with mild and moderate-to-severe Alzheimer disease: a comparative cross-sectional study
  17. Prevalence of anaemia among adults with Alzheimer disease and its association with cognitive severity: a cross-sectional study
  18. Association of haemoglobin concentration with cognitive performance among patients with Alzheimer disease: a cross-sectional analytical study
  19. Prevalence of vitamin B12 deficiency among older adults with dementia: a cross-sectional observational study
  20. Association of vitamin B12 status with cognitive impairment among adults with Alzheimer disease: a cross-sectional analytical study
  21. Comparison of cognitive performance between Alzheimer disease patients with normal and low vitamin B12 levels: a comparative cross-sectional study
  22. Prevalence of vitamin D deficiency among older adults with Alzheimer disease: a cross-sectional study
  23. Association of serum vitamin D levels with cognitive and functional impairment among patients with Alzheimer disease: a cross-sectional analytical study
  24. Prevalence of thyroid dysfunction among adults presenting with dementia syndrome: a cross-sectional observational study
  25. Association of thyroid-stimulating hormone concentration with cognitive performance among older adults with dementia: a cross-sectional analytical study
  26. Comparison of metabolic abnormalities between older adults with dementia and cognitively normal older adults: a comparative cross-sectional study
  27. Prevalence of diabetes mellitus among adults with Alzheimer disease and its association with cognitive severity: a cross-sectional study
  28. Association of glycaemic control with cognitive performance among patients with Alzheimer disease and diabetes mellitus: a cross-sectional analytical study
  29. Comparison of cognitive and functional characteristics of Alzheimer disease patients with and without diabetes mellitus: a comparative cross-sectional study
  30. Association of hypertension with cognitive impairment among older adults with Alzheimer disease: a cross-sectional analytical study
  31. Prevalence of dyslipidaemia among adults with Alzheimer disease and its association with cognitive severity: a cross-sectional study
  32. Association of metabolic syndrome with cognitive and functional impairment among older adults with dementia: a cross-sectional analytical study
  33. Comparison of cardiovascular risk-factor burden between patients with Alzheimer disease and cognitively normal older adults: a comparative cross-sectional study
  34. Prevalence of orthostatic hypotension among older adults with dementia: a cross-sectional observational study
  35. Association of orthostatic hypotension with falls among older adults with dementia: a cross-sectional analytical study
  36. Prevalence of falls among older adults with Alzheimer disease and their associated clinical factors: a cross-sectional study
  37. Comparison of cognitive and functional characteristics of dementia patients with and without recurrent falls: a comparative cross-sectional study
  38. Association of gait speed with cognitive impairment among older adults with Alzheimer disease: a cross-sectional analytical study
  39. Relationship between handgrip strength and functional dependence among older adults with dementia: a cross-sectional observational study
  40. Prevalence of sarcopenia among older adults with Alzheimer disease and its association with functional impairment: a cross-sectional study
  41. Association of frailty with cognitive severity among older adults with dementia: a cross-sectional analytical study
  42. Comparison of nutritional status, frailty, and functional dependence among patients with mild and advanced dementia: a comparative cross-sectional study
  43. Prevalence of urinary incontinence among older adults with dementia and its association with disease severity: a cross-sectional study
  44. Association of constipation with functional dependence among older adults with dementia: a cross-sectional analytical study
  45. Prevalence of swallowing difficulty among adults with Alzheimer disease: a cross-sectional observational study
  46. Association of dysphagia with nutritional impairment among patients with dementia: a cross-sectional analytical study
  47. Comparison of nutritional parameters between dementia patients with and without dysphagia: a comparative cross-sectional study
  48. Clinical profile of adults presenting with rapidly progressive cognitive decline to a tertiary care medicine department: a cross-sectional observational study
  49. Aetiological spectrum of dementia among older adults attending a tertiary care hospital: a cross-sectional study
  50. Comparison of clinical characteristics of Alzheimer disease and vascular dementia among older adults: a comparative cross-sectional study
  51. Association of vascular risk-factor burden with severity of cognitive impairment among older adults with dementia: a cross-sectional analytical study
  52. Comparison of executive, memory, and visuospatial impairment in Alzheimer disease and vascular dementia: a comparative cross-sectional study
  53. Prevalence of mixed dementia among older adults evaluated for cognitive decline: a cross-sectional observational study
  54. Association of cerebral small-vessel disease burden on neuroimaging with cognitive impairment among older adults with dementia: a cross-sectional analytical study
  55. Comparison of functional dependence in Alzheimer disease, vascular dementia, and mixed dementia: a comparative cross-sectional study
  56. Relationship between medial temporal lobe atrophy on neuroimaging and cognitive severity among adults with Alzheimer disease: a cross-sectional observational study
  57. Association of global cerebral atrophy with functional impairment among older adults with dementia: a cross-sectional analytical study
  58. Comparison of cognitive performance between patients with predominant cortical and subcortical neuroimaging changes: a comparative cross-sectional study
  59. Prevalence of potentially reversible metabolic contributors among adults presenting with dementia syndrome: a cross-sectional study
  60. Clinical, nutritional, metabolic, cognitive, and functional profile of older adults with dementia attending a tertiary care medicine service: a cross-sectional observational study

Motor Neuron Disease

  1. Clinical profile and pattern of neurological involvement among adults with motor neuron disease: a cross-sectional observational study
  2. Distribution of limb-onset and bulbar-onset motor neuron disease among adults attending a tertiary care hospital: a cross-sectional study
  3. Comparison of clinical characteristics of limb-onset and bulbar-onset motor neuron disease: a comparative cross-sectional study
  4. Association of age at symptom onset with functional disability among adults with motor neuron disease: a cross-sectional analytical study
  5. Relationship between duration of symptoms and functional impairment among patients with motor neuron disease: a cross-sectional observational study
  6. Prevalence of respiratory symptoms among adults with motor neuron disease: a cross-sectional study
  7. Association of respiratory symptom burden with functional disability among adults with motor neuron disease: a cross-sectional analytical study
  8. Relationship between bedside respiratory parameters and functional severity among patients with motor neuron disease: a cross-sectional observational study
  9. Comparison of respiratory impairment between bulbar-onset and limb-onset motor neuron disease: a comparative cross-sectional study
  10. Prevalence of orthopnea among adults with motor neuron disease and its association with respiratory muscle weakness: a cross-sectional study
  11. Association of resting oxygen saturation with respiratory symptom burden among patients with motor neuron disease: a cross-sectional analytical study
  12. Prevalence of swallowing difficulty among adults with motor neuron disease: a cross-sectional observational study
  13. Association of dysphagia severity with nutritional status among patients with motor neuron disease: a cross-sectional analytical study
  14. Comparison of nutritional parameters between motor neuron disease patients with and without bulbar involvement: a comparative cross-sectional study
  15. Prevalence of undernutrition among adults with motor neuron disease and its association with functional impairment: a cross-sectional study
  16. Association of body mass index with functional severity among adults with motor neuron disease: a cross-sectional analytical study
  17. Relationship between mid-upper arm circumference and functional status among patients with motor neuron disease: a cross-sectional observational study
  18. Comparison of anthropometric indices between patients with mild and severe motor neuron disease: a comparative cross-sectional study
  19. Prevalence of anaemia among adults with motor neuron disease and its association with functional disability: a cross-sectional study
  20. Association of serum albumin concentration with nutritional and functional status among patients with motor neuron disease: a cross-sectional analytical study
  21. Prevalence of vitamin D deficiency among adults with motor neuron disease: a cross-sectional observational study
  22. Association of serum vitamin D concentration with muscle weakness severity among adults with motor neuron disease: a cross-sectional analytical study
  23. Prevalence of vitamin B12 deficiency among adults with suspected motor neuron disease: a cross-sectional study
  24. Comparison of biochemical nutritional parameters between patients with bulbar and non-bulbar motor neuron disease: a comparative cross-sectional study
  25. Prevalence of cognitive impairment among adults with motor neuron disease: a cross-sectional observational study
  26. Association of executive dysfunction with functional severity among patients with motor neuron disease: a cross-sectional analytical study
  27. Comparison of cognitive performance between motor neuron disease patients with and without bulbar involvement: a comparative cross-sectional study
  28. Prevalence of behavioural symptoms among adults with motor neuron disease: a cross-sectional study
  29. Association of behavioural abnormalities with executive dysfunction among patients with motor neuron disease: a cross-sectional analytical study
  30. Prevalence of depressive symptoms among adults with motor neuron disease and their association with disability: a cross-sectional observational study
  31. Association of anxiety symptoms with respiratory and swallowing impairment among patients with motor neuron disease: a cross-sectional analytical study
  32. Comparison of psychological symptom burden between patients with early and advanced motor neuron disease: a comparative cross-sectional study
  33. Prevalence of sleep disturbance among adults with motor neuron disease: a cross-sectional study
  34. Association of sleep quality with respiratory symptoms among patients with motor neuron disease: a cross-sectional analytical study
  35. Prevalence of cramps and fasciculations among adults with motor neuron disease and their association with disease severity: a cross-sectional observational study
  36. Association of upper motor neuron signs with functional disability among adults with motor neuron disease: a cross-sectional analytical study
  37. Comparison of clinical characteristics of patients with predominantly upper motor neuron and predominantly lower motor neuron involvement: a comparative cross-sectional study
  38. Clinical profile of adults presenting with progressive muscular weakness suspected to have motor neuron disease: a cross-sectional observational study
  39. Comparison of clinical and electrophysiological findings among different phenotypes of motor neuron disease: a comparative cross-sectional study
  40. Clinical, respiratory, nutritional, cognitive, and functional profile of adults with motor neuron disease: a cross-sectional observational study

Atypical Parkinsonian Disorders

  1. Clinical spectrum of atypical parkinsonian disorders among adults attending a tertiary care hospital: a cross-sectional observational study
  2. Comparison of clinical characteristics of Parkinson disease and atypical parkinsonian disorders: a comparative cross-sectional study
  3. Association of early postural instability with atypical parkinsonism among adults presenting with parkinsonian features: a cross-sectional analytical study
  4. Association of early autonomic dysfunction with atypical parkinsonian disorders among adults with parkinsonism: a cross-sectional analytical study
  5. Comparison of gait abnormalities between Parkinson disease and progressive supranuclear palsy: a comparative cross-sectional study
  6. Clinical profile of progressive supranuclear palsy among adults attending a tertiary care centre: a cross-sectional observational study
  7. Prevalence of falls among adults with progressive supranuclear palsy and their association with functional impairment: a cross-sectional study
  8. Association of vertical gaze abnormality with disease severity among patients with progressive supranuclear palsy: a cross-sectional analytical study
  9. Comparison of cognitive impairment between progressive supranuclear palsy and Parkinson disease: a comparative cross-sectional study
  10. Prevalence of frontal executive dysfunction among adults with progressive supranuclear palsy: a cross-sectional observational study
  11. Clinical profile of multiple system atrophy among adults presenting with atypical parkinsonism: a cross-sectional observational study
  12. Prevalence of orthostatic hypotension among adults with multiple system atrophy: a cross-sectional study
  13. Association of autonomic dysfunction severity with functional disability among patients with multiple system atrophy: a cross-sectional analytical study
  14. Comparison of autonomic symptoms in multiple system atrophy and Parkinson disease: a comparative cross-sectional study
  15. Prevalence of urinary dysfunction among adults with multiple system atrophy and its association with disease severity: a cross-sectional observational study
  16. Comparison of parkinsonian and cerebellar phenotypes of multiple system atrophy: a comparative cross-sectional study
  17. Clinical profile of corticobasal syndrome among adults attending a tertiary care hospital: a cross-sectional observational study
  18. Association of cortical sensory deficits with functional disability among adults with corticobasal syndrome: a cross-sectional analytical study
  19. Comparison of cognitive impairment in corticobasal syndrome and progressive supranuclear palsy: a comparative cross-sectional study
  20. Prevalence of apraxia among adults with corticobasal syndrome and its association with disability: a cross-sectional study
  21. Comparison of swallowing impairment across Parkinson disease, progressive supranuclear palsy, and multiple system atrophy: a comparative cross-sectional study
  22. Comparison of orthostatic blood pressure abnormalities across Parkinson disease and atypical parkinsonian disorders: a comparative cross-sectional study
  23. Association of early falls, dysphagia, and autonomic dysfunction with atypical parkinsonism among adults with parkinsonian syndromes: a cross-sectional analytical study
  24. Comparison of nutritional status among patients with Parkinson disease, progressive supranuclear palsy, and multiple system atrophy: a comparative cross-sectional study
  25. Clinical, cognitive, autonomic, and functional characteristics of common atypical parkinsonian disorders: a cross-sectional observational study

Frontotemporal Dementia

  1. Clinical and behavioural profile of adults with frontotemporal dementia attending a tertiary care hospital: a cross-sectional observational study
  2. Distribution of behavioural and language-predominant presentations among adults with frontotemporal dementia: a cross-sectional study
  3. Comparison of clinical characteristics of behavioural variant frontotemporal dementia and Alzheimer disease: a comparative cross-sectional study
  4. Association of age at symptom onset with behavioural severity among adults with frontotemporal dementia: a cross-sectional analytical study
  5. Prevalence of disinhibition among adults with behavioural variant frontotemporal dementia: a cross-sectional observational study
  6. Association of apathy with functional impairment among adults with frontotemporal dementia: a cross-sectional analytical study
  7. Prevalence of altered eating behaviour among patients with frontotemporal dementia and its association with disease severity: a cross-sectional study
  8. Association of compulsive behaviour with executive dysfunction among adults with frontotemporal dementia: a cross-sectional analytical study
  9. Comparison of executive dysfunction between frontotemporal dementia and Alzheimer disease: a comparative cross-sectional study
  10. Comparison of memory impairment between frontotemporal dementia and Alzheimer disease: a comparative cross-sectional study
  11. Prevalence of language impairment among adults with frontotemporal dementia: a cross-sectional observational study
  12. Comparison of clinical features of semantic and non-fluent language-predominant degenerative syndromes: a comparative cross-sectional study
  13. Association of frontal lobe atrophy on neuroimaging with behavioural symptom burden in frontotemporal dementia: a cross-sectional analytical study
  14. Comparison of neuroimaging patterns in frontotemporal dementia and Alzheimer disease: a comparative cross-sectional study
  15. Prevalence of parkinsonian features among adults with frontotemporal dementia: a cross-sectional study
  16. Association of parkinsonian features with functional impairment among patients with frontotemporal dementia: a cross-sectional analytical study
  17. Prevalence of motor neuron features among adults with frontotemporal dementia: a cross-sectional observational study
  18. Comparison of cognitive and behavioural manifestations in frontotemporal dementia with and without motor neuron features: a comparative cross-sectional study
  19. Association of nutritional status with altered eating behaviour among adults with frontotemporal dementia: a cross-sectional analytical study
  20. Clinical, behavioural, cognitive, nutritional, and neuroimaging profile of adults with frontotemporal dementia: a cross-sectional observational study

Dementia with Lewy Bodies

  1. Clinical and cognitive profile of adults with dementia with Lewy bodies attending a tertiary care hospital: a cross-sectional observational study
  2. Prevalence of visual hallucinations among adults with dementia with Lewy bodies: a cross-sectional study
  3. Association of visual hallucination burden with cognitive severity among patients with dementia with Lewy bodies: a cross-sectional analytical study
  4. Prevalence of cognitive fluctuations among adults with dementia with Lewy bodies: a cross-sectional observational study
  5. Association of cognitive fluctuations with functional dependence among adults with dementia with Lewy bodies: a cross-sectional analytical study
  6. Prevalence of parkinsonian features among adults with dementia with Lewy bodies: a cross-sectional study
  7. Association of parkinsonian severity with functional disability among patients with dementia with Lewy bodies: a cross-sectional analytical study
  8. Comparison of cognitive profile between dementia with Lewy bodies and Alzheimer disease: a comparative cross-sectional study
  9. Comparison of visuospatial impairment between dementia with Lewy bodies and Alzheimer disease: a comparative cross-sectional study
  10. Comparison of extrapyramidal manifestations between dementia with Lewy bodies and Parkinson disease dementia: a comparative cross-sectional study
  11. Prevalence of probable rapid eye movement sleep behaviour disorder among adults with dementia with Lewy bodies: a cross-sectional observational study
  12. Association of probable rapid eye movement sleep behaviour disorder with hallucinations in dementia with Lewy bodies: a cross-sectional analytical study
  13. Prevalence of orthostatic hypotension among adults with dementia with Lewy bodies: a cross-sectional study
  14. Association of autonomic dysfunction with functional dependence among patients with dementia with Lewy bodies: a cross-sectional analytical study
  15. Comparison of autonomic symptom burden between dementia with Lewy bodies and Alzheimer disease: a comparative cross-sectional study
  16. Prevalence of depressive and anxiety symptoms among adults with dementia with Lewy bodies: a cross-sectional observational study
  17. Association of depressive symptoms with functional impairment among patients with dementia with Lewy bodies: a cross-sectional analytical study
  18. Comparison of sleep disturbance between dementia with Lewy bodies and Alzheimer disease: a comparative cross-sectional study
  19. Association of gait impairment and postural instability with falls among adults with dementia with Lewy bodies: a cross-sectional analytical study
  20. Clinical, cognitive, neuropsychiatric, autonomic, and motor profile of adults with dementia with Lewy bodies: a cross-sectional observational study

Huntington Disease and Hereditary Choreiform Disorders

  1. Clinical profile of adults with Huntington disease attending a tertiary care hospital: a cross-sectional observational study
  2. Association of age at symptom onset with motor severity among adults with Huntington disease: a cross-sectional analytical study
  3. Relationship between chorea severity and functional disability among patients with Huntington disease: a cross-sectional observational study
  4. Prevalence of cognitive impairment among adults with Huntington disease: a cross-sectional study
  5. Association of executive dysfunction with motor severity among patients with Huntington disease: a cross-sectional analytical study
  6. Prevalence of depressive symptoms among adults with Huntington disease: a cross-sectional observational study
  7. Association of depressive symptom burden with functional disability among patients with Huntington disease: a cross-sectional analytical study
  8. Prevalence of behavioural abnormalities among adults with Huntington disease and their association with cognitive impairment: a cross-sectional study
  9. Comparison of motor, cognitive, and behavioural characteristics of younger and older adults with Huntington disease: a comparative cross-sectional study
  10. Association of nutritional status with disease severity among adults with Huntington disease: a cross-sectional analytical study
  11. Prevalence of undernutrition among adults with Huntington disease: a cross-sectional observational study
  12. Association of swallowing difficulty with nutritional impairment among patients with Huntington disease: a cross-sectional analytical study
  13. Clinical profile of adults presenting with hereditary choreiform movements: a cross-sectional observational study
  14. Comparison of clinical characteristics of Huntington disease and non-Huntington hereditary choreiform disorders: a comparative cross-sectional study
  15. Clinical, cognitive, psychiatric, nutritional, and functional profile of adults with hereditary choreiform neurodegenerative disorders: a cross-sectional observational study

Spinocerebellar and Degenerative Ataxias

  1. Clinical spectrum of adult-onset degenerative ataxias presenting to a tertiary care hospital: a cross-sectional observational study
  2. Distribution of hereditary and sporadic degenerative ataxias among adults with chronic progressive ataxia: a cross-sectional study
  3. Association of age at symptom onset with functional impairment among adults with degenerative ataxia: a cross-sectional analytical study
  4. Relationship between gait ataxia severity and functional disability among adults with degenerative ataxia: a cross-sectional observational study
  5. Comparison of clinical characteristics of hereditary and sporadic adult-onset degenerative ataxias: a comparative cross-sectional study
  6. Prevalence of peripheral neuropathy among adults with spinocerebellar degeneration: a cross-sectional study
  7. Association of peripheral neuropathy with gait impairment among adults with degenerative ataxia: a cross-sectional analytical study
  8. Prevalence of pyramidal signs among adults with hereditary spinocerebellar ataxia: a cross-sectional observational study
  9. Association of pyramidal signs with functional disability among adults with spinocerebellar degeneration: a cross-sectional analytical study
  10. Prevalence of extrapyramidal manifestations among adults with degenerative ataxia: a cross-sectional study
  11. Comparison of clinical characteristics of degenerative ataxia patients with and without extrapyramidal manifestations: a comparative cross-sectional study
  12. Prevalence of cognitive impairment among adults with hereditary degenerative ataxia: a cross-sectional observational study
  13. Association of executive dysfunction with functional disability among adults with degenerative ataxia: a cross-sectional analytical study
  14. Prevalence of depressive symptoms among adults with degenerative ataxia and their association with disease severity: a cross-sectional study
  15. Association of dysphagia with nutritional impairment among adults with degenerative ataxia: a cross-sectional analytical study
  16. Comparison of nutritional status between patients with mild and severe degenerative ataxia: a comparative cross-sectional study
  17. Prevalence of autonomic symptoms among adults with degenerative ataxia: a cross-sectional observational study
  18. Association of orthostatic hypotension with functional severity among patients with degenerative ataxia: a cross-sectional analytical study
  19. Comparison of clinical and functional characteristics of cerebellar-predominant and multisystem degenerative ataxias: a comparative cross-sectional study
  20. Clinical, neurological, cognitive, autonomic, and functional profile of adults with degenerative ataxias: a cross-sectional observational study

Mild Cognitive Impairment and Early Neurodegenerative Cognitive Syndromes

  1. Prevalence of mild cognitive impairment among older adults attending a general medicine outpatient department: a cross-sectional study
  2. Clinical and cognitive profile of older adults with mild cognitive impairment: a cross-sectional observational study
  3. Association of age and educational status with mild cognitive impairment among older adults: a cross-sectional analytical study
  4. Comparison of demographic and clinical characteristics of older adults with and without mild cognitive impairment: a comparative cross-sectional study
  5. Association of hypertension with mild cognitive impairment among older adults: a cross-sectional analytical study
  6. Prevalence of mild cognitive impairment among adults with type 2 diabetes mellitus: a cross-sectional study
  7. Association of glycated haemoglobin with cognitive performance among adults with type 2 diabetes mellitus: a cross-sectional analytical study
  8. Comparison of cognitive performance between older adults with and without diabetes mellitus: a comparative cross-sectional study
  9. Association of metabolic syndrome with mild cognitive impairment among older adults: a cross-sectional analytical study
  10. Prevalence of vitamin B12 deficiency among older adults with mild cognitive impairment: a cross-sectional observational study
  11. Association of vitamin B12 status with cognitive performance among older adults with mild cognitive impairment: a cross-sectional analytical study
  12. Prevalence of vitamin D deficiency among older adults with mild cognitive impairment: a cross-sectional study
  13. Association of serum vitamin D concentration with cognitive performance among older adults: a cross-sectional analytical study
  14. Association of anaemia with mild cognitive impairment among older adults attending a medicine outpatient department: a cross-sectional analytical study
  15. Comparison of nutritional status between older adults with normal cognition and mild cognitive impairment: a comparative cross-sectional study
  16. Association of frailty with mild cognitive impairment among older adults: a cross-sectional analytical study
  17. Relationship between handgrip strength and cognitive performance among older adults: a cross-sectional observational study
  18. Association of gait speed with mild cognitive impairment among community-dwelling older adults: a cross-sectional analytical study
  19. Comparison of sleep quality between older adults with normal cognition and mild cognitive impairment: a comparative cross-sectional study
  20. Association of depressive symptoms, sleep disturbance, frailty, and nutritional status with mild cognitive impairment among older adults: a cross-sectional analytical study

Cross-Cutting Neurodegenerative Disease Syndromes and Comorbidities

  1. Comparison of nutritional impairment across Parkinson disease, dementia, and motor neuron disease: a comparative cross-sectional study
  2. Comparison of vitamin B12 deficiency among adults with Parkinson disease, dementia, and motor neuron disease: a comparative cross-sectional study
  3. Comparison of vitamin D deficiency among adults with common neurodegenerative disorders: a comparative cross-sectional study
  4. Association of frailty with functional dependence among older adults with neurodegenerative diseases: a cross-sectional analytical study
  5. Comparison of frailty prevalence among patients with Parkinson disease, Alzheimer disease, and dementia with Lewy bodies: a comparative cross-sectional study
  6. Association of sarcopenia with functional disability among older adults with neurodegenerative disease: a cross-sectional analytical study
  7. Comparison of handgrip strength among adults with Parkinson disease, dementia, and age-matched individuals without neurodegenerative disease: a comparative cross-sectional study
  8. Prevalence of polypharmacy among older adults with neurodegenerative disorders and its association with falls: a cross-sectional study
  9. Association of potentially inappropriate medication use with orthostatic symptoms among older adults with neurodegenerative disease: a cross-sectional analytical study
  10. Comparison of fall risk among adults with Parkinson disease, dementia, and atypical parkinsonian disorders: a comparative cross-sectional study
  11. Prevalence of dysphagia among adults with common neurodegenerative disorders: a cross-sectional observational study
  12. Comparison of swallowing difficulty among Parkinson disease, motor neuron disease, and atypical parkinsonian disorders: a comparative cross-sectional study
  13. Association of dysphagia with nutritional impairment across common neurodegenerative diseases: a cross-sectional analytical study
  14. Prevalence of orthostatic hypotension among adults with Parkinson disease, dementia with Lewy bodies, and multiple system atrophy: a cross-sectional study
  15. Comparison of autonomic symptom burden among common neurodegenerative disorders presenting to a tertiary care hospital: a comparative cross-sectional study
  16. Association of sleep disturbance with functional disability among adults with neurodegenerative diseases: a cross-sectional analytical study
  17. Comparison of depressive symptom burden among adults with Parkinson disease, dementia, and motor neuron disease: a comparative cross-sectional study
  18. Association of anaemia, hypoalbuminemia, and vitamin deficiencies with functional impairment among adults with neurodegenerative disorders: a cross-sectional analytical study
  19. Comparison of cognitive, nutritional, gait, and functional abnormalities among older adults with Parkinson disease and major degenerative dementias: a comparative cross-sectional study
  20. Spectrum of neurological, cognitive, autonomic, nutritional, sleep-related, and functional abnormalities among adults with common neurodegenerative diseases attending a tertiary care medicine department: a cross-sectional observational study

Not the general medicine subspeciality you need? Neurodegenerative diseases is one section of our full general medicine collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Browse all General Medicine Thesis Topics →

📌 Updated for 2026–2027 MD Medicine/DNB Medicine Neurodegenerative Diseases admissions

The page has been reviewed for feasibility in postgraduate medicine departments where most neurodegenerative research depends on structured clinical phenotyping, validated rating scales and routinely available investigations.

  • Most projects can be completed with neurological examination, cognition and function scales, routine blood tests, gait or autonomic assessment and standard CT or MRI performed as part of clinical care.
  • Genetic panels, advanced molecular biomarkers, PET imaging and research-only neurophysiology are not required for most practical dissertation designs.
  • Publication potential is strongest when the protocol defines the syndrome precisely, uses named validated scales and records medication state, education, disease duration and major comorbidities that can distort measured impairment.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full neurodegenerative diseases protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside neurodegenerative diseases protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Neurodegenerative diseases research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the neurodegenerative diseases research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the neurodegenerative diseases research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a neurodegenerative diseases research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A neurodegenerative diseases IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning neurodegenerative diseases research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the neurodegenerative diseases research proposal is the document assessed at the start of it.

Kuwait — KIMS. A neurodegenerative diseases study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the neurodegenerative diseases proposal follows the same structure throughout.

Generate a neurodegenerative diseases research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A neurodegenerative diseases dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full neurodegenerative diseases research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about a neurodegenerative diseases PhD or MMed proposal →

🔥 Trending research areas in Neurodegenerative Diseases for 2026–27

Current dissertation opportunities increasingly focus on multidomain clinical phenotyping, early functional markers and reproducible bedside measures rather than descriptive case profiles alone.

  • Non-motor burden in Parkinson disease: cognition, sleep, autonomic dysfunction, mood and nutrition can be studied using validated scales and often explain disability beyond motor severity.
  • Frailty, sarcopenia and gait: these measures are increasingly useful across dementia and parkinsonian disorders because they connect neurological disease with falls, dependence and hospital outcomes.
  • Clinical-imaging correlation: medial temporal atrophy, small-vessel disease burden and regional atrophy patterns are useful when imaging ratings are predefined and interpreted independently of the cognitive score being correlated.
  • Phenotype differentiation: comparative work between Parkinson disease, atypical parkinsonism and major dementia syndromes can be valuable when diagnostic criteria and red-flag features are fixed before enrolment.

Protocol and synopsis guidance

What a Neurodegenerative Diseases protocol must contain

Case definition: State the clinical criteria used to classify Parkinson disease, Alzheimer disease, dementia with Lewy bodies, motor neuron disease, atypical parkinsonism or another syndrome. Avoid relying only on a previous chart label, particularly when phenotypes overlap.

Measurement instrument: Name the exact motor, cognitive, behavioural, autonomic or functional scale and the version or language used. A score is interpretable only if the protocol states who administers it, under what conditions and how missing items are handled.

Medication state: In Parkinson disease and related disorders, motor examination can differ substantially between medication ON and OFF states. The protocol should fix the examination state rather than mix measurements obtained at arbitrary times after dopaminergic therapy.

Education and sensory confounding: Cognitive scores are influenced by education, literacy, vision, hearing and language. These factors must be recorded because a low score does not automatically represent neurodegenerative cognitive decline.

Function versus impairment: Functional dependence can be caused by motor disability, frailty, arthritis, stroke or sensory loss as well as cognition. The protocol should distinguish the neurological construct being measured from general disability.

Neurodegenerative Diseases synopsis versus Neurodegenerative Diseases protocol

Synopsis: The synopsis should state the target neurodegenerative syndrome, study design, principal scale or measurement, main exposure or comparison and the primary outcome in a concise form suitable for academic review.

Protocol: The protocol must define diagnostic criteria, medication state where relevant, examiner training, scale version, language, education adjustment, imaging interpretation method, confounders and the precise time point of assessment.

Why the distinction matters: A synopsis may say that cognitive impairment will be associated with Parkinson disease severity, but the protocol must specify which cognitive test is used, whether education-adjusted thresholds are applied, whether testing occurs during a defined medication state and how depression, hearing impairment or delirium will be excluded.

Sample size and statistical analysis

Base the calculation on the primary objective: Estimating prevalence of cognitive impairment, comparing two phenotypes, correlating a motor score with disability and identifying predictors of falls each require different sample-size assumptions.

Respect scale structure: Ordinal motor or functional scores should not automatically be treated as normally distributed continuous variables. Distribution, ceiling effects and floor effects should be checked before choosing parametric tests.

Control major confounders: Age, sex, education, disease duration, medication burden, vascular risk factors, depression, frailty and sensory impairment can alter cognition and function. Multivariable analysis should be planned when these variables are central to the research question.

Avoid circular correlations: If a severity scale already contains gait, falls or activities-of-daily-living items, correlating that total score with another measure containing the same items may produce an inflated association. Overlapping constructs should be identified before analysis.

Frequently Asked Questions – Neurodegenerative Diseases Thesis Topics (2026–27)

1. How do I choose a feasible Neurodegenerative Diseases topic for the 2026–2027 academic year?

Choose a syndrome with sufficient case volume in your medicine or neurology service and a question that can be answered with routinely available clinical assessment. Parkinson disease, common dementias and mixed neurodegenerative clinics usually provide more realistic recruitment than very rare hereditary disorders. Prefer one primary domain such as cognition, gait, autonomic dysfunction, nutrition or functional disability rather than combining many unrelated outcomes into one dissertation.

2. Which study designs are usually accepted for a Neurodegenerative Diseases dissertation?

Commonly feasible designs include cross-sectional observational and analytical studies, comparative studies between well-defined clinical phenotypes, retrospective record-based cohorts, prospective cohorts with a short functional outcome and case-control designs for selected associations. Diagnostic differentiation studies are possible if every group is classified using predefined criteria rather than clinician impression alone.

3. What should I settle with my guide before finalising a Neurodegenerative Diseases topic?

Agree on the exact diagnostic criteria, primary scale, language version, assessor, medication state, cognitive exclusion criteria, imaging variables, expected case load and the primary statistical comparison. These choices should be fixed before recruitment because changing scales or case definitions midway makes interpretation difficult.

4. Can I use routine cognitive and functional scales in a Neurodegenerative Diseases thesis?

Yes, provided the instrument is validated for the population and the protocol specifies how it is administered. Education, literacy, hearing, vision, depression and language can alter cognitive performance, while physical disability can alter functional scores independently of cognition. These influences should be measured or controlled rather than treated as noise.

5. What is the difference between a Neurodegenerative Diseases synopsis and a Neurodegenerative Diseases protocol?

The synopsis presents the research question, target syndrome, study design, principal variables and broad analysis plan. The protocol converts that idea into a reproducible method by defining diagnostic criteria, scale administration, medication state, examiner procedures, confounders, imaging assessment, sample size and statistical methods.

6. What ethical issues should I address in a Neurodegenerative Diseases study?

Cognitive impairment may affect capacity to consent, so the protocol should state how decision-making capacity will be assessed and when a legally acceptable representative will provide consent. Participants who retain capacity should consent directly. If children are exceptionally included in a hereditary disorder study, guardian consent and child assent from about seven years should be addressed. Record-based work may qualify for an ethics-approved waiver of consent.

No additional radiation, contrast study, research-only MRI sequence or research-only venepuncture should be added unless scientifically necessary and ethically approved. If extra blood sampling is required, the protocol should state the blood-volume limit. Separate consent should be obtained for identifiable photographs or video of gait, tremor or movement phenomenology. Incidental clinically important findings on neuroimaging or laboratory testing should have a named escalation pathway to the treating clinician. Imaging datasets should be anonymised because DICOM headers and reconstructed facial surfaces can contain identifiers.

7. How do I avoid misclassifying severity in Parkinson disease and dementia research?

Use a named validated scale and standardise the conditions under which it is applied. In Parkinson disease, motor severity should be assessed in a predefined medication state because an examination performed soon after levodopa cannot be compared directly with one performed when the patient is OFF medication. In dementia research, cognitive scores should be interpreted with education, literacy, language, hearing, vision and mood in mind. Functional dependence should not be assumed to represent cognitive severity because gait impairment, frailty, stroke and musculoskeletal disease can independently reduce activities of daily living.

8. Can a Neurodegenerative Diseases dissertation later support a PhD or Gulf board research pathway?

Yes, but the scope and documentation differ. An MD or DNB synopsis is usually a time-limited residency dissertation plan, whereas a PhD proposal generally requires a broader research programme, stronger justification of the knowledge gap and more extensive methodology. Gulf pathways may separately require a board research project or proposal under SCFHS and the Saudi Board, the Arab Board of Health Specializations, or DHP, DHA, DOH and MOHAP-linked programmes. The same clinical question may sometimes be adapted, but supervision, ethics, format and institutional requirements should be checked for the specific programme.

9. When should I register my Neurodegenerative Diseases dissertation?

Register after the diagnostic criteria, principal scale, primary objective, sample-size basis and expected recruitment rate have been agreed with the guide. It is particularly important to confirm that the selected syndrome appears frequently enough in the department and that the chosen assessment tool can be administered consistently throughout the study period.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×